[DOI] [PMC free article] [PubMed] [Google Scholar] 10.Lincoff A.M., Brown-Frandsen K., Colhoun H.M., Deanfield J., Emerson S.S., Esbjerg S., et al
Judicial Panel on Multidistrict Litigation (JPML) issued a transfer order on February 2, centralizing all Ozempic lawsuits , Wegovy lawsuits and other GLP1 stomach paralysis lawsuits in the U.S
Ipamorelin's foundational characterisation as the first selective growth hormone secretagogue is anchored by the 1998 Raun paper in the European Journal of Endocrinology (PMID 9849822)
Costello: Glucagon-Like Peptide-1 Receptor Agonists
MWLB data reveal an average 18.3% loss at 12 months and 16.1% at 24 months, with fat percentage decreasing from 47.1 to 35.5, so long-term monitoring counts
Li X, Zhang K, He X, Zhou J, Jin C, Shen L, et al